Leon Lih-Ren Su

Title: The Innovations of Leon Lih-Ren Su

Introduction

Leon Lih-Ren Su is an accomplished inventor based in Mountain View, California. He has made significant contributions to the field of biotechnology, particularly in the development of interleukin-2 muteins. His work has implications for the treatment of autoimmune diseases, showcasing the potential of his innovations in medical applications.

Latest Patents

Leon Lih-Ren Su holds a patent for "Partial agonists of interleukin-2." This patent provides human interleukin-2 (IL-2) muteins or variants that exhibit a decreased binding capacity for IL-2Rγ. These IL-2 muteins serve as partial agonists in applications where the reduction or inhibition of IL-2 and/or IL-15 functions is beneficial, such as in treating autoimmune diseases. The patent also includes nucleic acids encoding these IL-2 muteins, methods for their production, and pharmaceutical compositions that incorporate them.

Career Highlights

Leon Lih-Ren Su is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovations. His work is characterized by a commitment to improving therapeutic strategies through innovative biotechnological solutions.

Collaborations

Some of his notable coworkers include Kenan Christopher Garcia and Sonia S Majri. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Leon Lih-Ren Su's contributions to the field of biotechnology, particularly through his patent on interleukin-2 muteins, highlight his role as an innovative inventor. His work has the potential to significantly impact the treatment of autoimmune diseases and advance medical science.